The product of these Ensembles should result in the identification and removal of obstacles and roadblocks that slow the performance and progress of Translational Research and expedite the delivery of healthcare solutions. Teams will form around an identified translational barrier of their choice, and create solutions that accelerate the translational process.
KEY DATES
October 11, 2023 – RFA Release
October 16, 2023 – Begin Consultation Sessions
October 31, 2023: – Town Hall RFA Discussion (Virtual) at Noon.* Meeting Link
November 1, 2023: – Town Hall RFA Discussion (Virtual) at 5pm.* Meeting Link
November 27, 2023: – Letter of Intent (Required)
By December 15, 2023: – Begin Pre-Ensemble meetings (Required) with CTSI Project Manager and applicant team for team building, development of shared goals, and proposal development.
March 11, 2024 – Proposal Deadline; Allows ~5 months for Pre-Ensemble meetings and proposal development
April 8, 2024 – Start Date
This is a unique opportunity in which non-traditional investigators or “translational research accelerators” could apply such as experts in clinical trial protocol development, patient recruitment and retention, budget development, grant management, clinical research coordination, project management, human subject research regulations and processes (IRB), advertising and communications, legal and risk management, intellectual property, etc.
All investigators and translational research accelerators at CTSI partner institutions are eligible to participate in this funding opportunity. Partner institutions include Medical College of Wisconsin, University of WisconsinMilwaukee, Marquette University, Milwaukee School of Engineering, Children’s Wisconsin, Versiti Blood Center, Froedtert Hospital, and Zablocki Veterans Affairs Medical Center.
NIH Funding Acknowledgment:Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.
